Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2000-02-03
2003-02-25
Murthy, Ponnathapuachuta (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
Reexamination Certificate
active
06524837
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention to previously isolated hydantoinases and their use in whole-cell catalysts to manufacture amino acids.
2. Description of Related Art
Hydantoin hydrolyzing enzymes, which will be referred here as ‘hydantoinases’, comprise a diverse class of enzymes having a wide range of specificities and biological functions. Some hydantoinases for example play an essential role in the reductive pathway of pyrimidine degradation (dihydropyrimidinases, EC 3.5.2.2) whereas others catalyze reactions in the purine degradation pathway (allantoinases, EC 3.5.2.5). Despite their functional diversity hydantoinases show significant sequence similarities and belong to a superfamily of amidohydrolases related to ureases as described by Holm, L., and Sander, C. (1997) An evolutionary treasure: Unification of a broad set of amidohydrolases related to ureases,
Proteins
28:72-82; The alignment of sequences from the different hydantoinases was used to identify conserved residues that are important for catalytic function as described by May, O., Habenicht, A., Mattes, R., Syldatk, C. and Siemann, M. (1998) Molecular Evolution of Hydantoinases,
Biol Chem
. 379:743-747; and Kim, G. J. and Kim, H. S. (1998) Identification of the structural similarity in the functionally related amidohydrolases acting on the cyclic amide ring.
Biochem. J
. 330:295-302. Despite this knowledge that allows to identify equivalent amino acid residues of the different hydantoinases, knowledge about the function of other amino acid residues is limited. So far, no X-ray structure of hydantoinases was reported.
An important property of hydantoinases is their enantioselectivity which makes them valuable for the production of optically pure D- or L-amino acids. A detailed background of hydantoinases is provided in the published doctoral thesis of Oliver May entitled “The Hydantoinase from
Arthrobacter aurescens
DSM 3745 and its Relation to other Hydantoinases” (Institut fuer Bioverfahrenstechnik, Lehrstuhl Physiologische Mikrobiologie, Universitaet Stuttgart-1998).
In view of the importance of hydantoinases to the production of optically pure amino acids, there has been a concentrated effort to develop modified enzymes which have improved properties with respect to amino acid production. As a result of this effort, a number of microorganisms have been isolated and identified which produce hydantoinases with desirable enzymatic properties. U.S. Pat. No. 5,516,660 discloses microoganisms identified as DSM7329 and DSM 7330 which produce hydantoinases that are capable of producing L-alpha-amino acids from D-, L- and/or D,L-5-monosubstituted hydantoins. In U.S. Pat. No. 5,714,355, a mutant of the DSM 7330 microorganism is disclosed which has greater enzymatic activity than the parent organism by a factor of up to 2.7. The mutant (DSM 9771) was obtained by cultivating the parent DSM 7330 organism under selective pressure using L-carbamoylmethionine (L-CAM) as the sole source of nitrogen. Although the hydantoinases produced by the above-mentioned microoganisms are well-suited for at least some of their intended purposes, there still is a continuing need to develop new enzymes which exhibit even more desirable hydantoinase activity. In particular, there is a need to improve enantioselectivity as well as catalytic activity.
SUMMARY OF THE INVENTION
In accordance with the present invention, modified hydantoinases are provided which have enhanced enzymatic properties (better whole-cell catalysts) with respect to the hydantoinase produced by the microorganism DSM 9771 which is identified in U.S. Pat. No. 5,714,355. The DSM 9771 hydantoinase has an amino acid sequence which includes numbered positions ranging sequentially from 1 to 458 (SEQ. ID. NO. 2).
It was discovered that substitution of amino acids at one or more specific amino acid positions within the DSM 9771 enzyme resulted in the formation of enzymes having enhanced properties with respect to activity and enantioselectivity. The specific amino acid position numbers at which substitutions are made to achieve the modified hydantoinase enzymes in accordance with the present invention are positions Nos. 95, 154, 180, 251 and 295. As a further feature of the invention, specific amino acid substitutions at the various positions are identified to provide specific types of modified hydantoinases. The specific amino acid substitutions include 195F, I95L, V154A, V180A, Q251R and V295A. One or more of these specific substitutions were found to enhance the enzymatic activity and change the enantioselectivity of the “wild type” DSM 9771 hydantoinase. These changed enzyme properties were found to contribute to a significantly improved hydantoinase process by reducing the accumulation of the wrong enantiomer of the N-carbamoyl-amino acid.
Six specific modified hydantoinases are disclosed which have one or more of the above amino acid substitutions. The amino acid sequences for these modified hydantoinases are set forth in SEQ. ID. NOS. 4, 6, 8, 10, 12 and 14. These modified hydantoinases are also identified throughout the specification as 1CG7, 11DH7, 1BF7, 19AG11, 22CG2 and Q2H4, respectively.
It was further discovered that hydantoinases evolved for activity and/or enantioselectivity can dramatically improve the production of amino acids (i.e., L-methionine) using a whole cell catalyst comprising an evolved hydantoinase in addition to at least a carbamoylase.
The above discussed and many other features and attendant advantages of the present invention will become better understood by reference to the following detailed description when taken in conjunction with the accompanying drawings.
REFERENCES:
patent: 3964970 (1976-06-01), Dinelli et al.
patent: 4065353 (1977-12-01), Cecere et al.
patent: 4094741 (1978-06-01), Yamada et al.
patent: 4111749 (1978-09-01), Degen et al.
patent: 4816393 (1989-03-01), Siedel et al.
patent: 5516660 (1996-05-01), Wagner et al.
patent: 5608076 (1997-03-01), Kottenhahn et al.
patent: 5679571 (1997-10-01), Burtscher et al.
patent: 5714355 (1998-02-01), Wagner et al.
patent: 5807710 (1998-09-01), Galli et al.
patent: 5827717 (1998-10-01), Wagner et al.
patent: 5834258 (1998-11-01), Grifantini et al.
patent: 5877003 (1999-03-01), Grifantini et al.
GenBank Accession No. AAc09759 (1998).*
Mukohara et al. A thermostable hydantoinase ofBacillus stearothermophilusNS1122A: cloning, sequencing, and high expression of the enzyme gene, and some properties of the expressed enzyme. Biosci Biotechnol Biochem Sep 1994;58(9):1621-6.*
GenBank Accession No. Q45515 (Jul. 15, 1998).*
LaPointe et al. Cloning, sequencing, and expression inEscherichia coliof the D-hydantoinase gene fromPseudomonas putidaand distribution of homologous genes in other microorganisms. Appl Environ Microbiol Mar. 1994;60(3):888-95.*
GenBank Accession No. Q59699 (Jul. 15, 1998).*
Matsuda et al. Molecular cloning and sequencing of a cDNA encoding dihydropyrimidinase from the rat liver. Biochim Biophys Acta Jun. 7, 1996;1307(2):140-4.*
GenBank Accession No. Q63150 (Jul. 15, 1998).*
GenBank Accession No. JC5315 (May 1, 1997).*
May et al. Substrate-dependent enantioselectivity of a novel hydantoinase from Arthrobacter aurescens DSM 3745: purification and characterization as new member of cyclic amidase. J Biotechnol Mar. 26, 1998;61(1):1-13.*
GenBank Accession No. P81006 (Jul. 15, 1998).*
GenBank Accession No. CAA18902 (May 8, 1998).*
GenBank Accession No. Q44184 (Jul. 15, 1998).*
O. May (1998) “The Hydantoinase fromArthrobacter aurescensDSM 3745 and its Relation to other Hydantoinase,” Dissertation.
C. Syldatk et al. (1992) “Microbial and Enzymatic Production of D-Amino Acids from DL-5-Monosubstituted Hydantoins,” In: Biocatalytic Production of Amino Acids and Derivatives (Rozzell, J.D. & Wagner, F. eds.) Hanser Publishers, NY.
R. Grifantini et al. (1998) Efficient conversion of 5-substituted hydantoins to D-&khgr;-amino acids using recombinantEscherichia colistrains, Microbiology, 144, 947-954.
T. Wagner et al. (1996) Production of L-methionine from D,L-5-(2-methyl
Arnold Frances H.
Bommarius Andreas
Drauz Karlheinz
May Oliver
California Institute of Technology
Kerr Kathleen
Murthy Ponnathapuachuta
Shapiro & Dupont LLP
LandOfFree
Hydantoinase variants with improved properties and their use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoinase variants with improved properties and their use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoinase variants with improved properties and their use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3178791